GL1X · GenesisL1 explorer

MolNFT v1 · #168167 · protein

Lmfpps mutant T164W in complex with 476A, ipp & ca

6W7I · Farnesyl pyrophosphate synthase: “Lmfpps mutant T164W in complex with 476A, ipp & ca”. X-ray diffraction, 3 ligands (IPR, 476, CA), 8 pockets (best druggability 0.83). MolNFT v1 #168167 on GenesisL1: 3D structure, binding sites and…

PDB
6W7I
Type
protein
Length
724 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Farnesyl pyrophosphate synthase
EC
2.5.1.1, 2.5.1.10
UniProt
Q4QBL1
Ligands
IPR, 476, CA
Pockets
8 · best druggability 0.83

Structure

x-ray diffraction · 1 distinct chain · 74% helix, 2% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BFarnesyl pyrophosphate synthase (EC 2.5.1.1, 2.5.1.10)protein36274% helix, 2% strandQ4QBL1

Ligands and binding sites

  • IPR · Isopentyl pyrophosphate · ligand · 2 copies · chains A, B
  • 476 · 3-butyl-1-(2,2-diphosphonoethyl)pyridinium · ligand · 2 copies · chains A, B
  • CA · Calcium ion · metal · 6 copies · chains A, B
  • ACT · Acetate ion · additive · chains A
  • PEG · Di(hydroxyethyl)ether · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13390.830.9351CA, IPR, 476, PEG
23660.820.9160CA, IPR, 476
31100.470.7923empty
41210.460.7823empty
51010.410.7715empty

Interfaces

1 interface between chains.

  • A–B · 2960 Ų buried · 46 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 modified (formylation).

Compared structures

  • 6W7I · LmFPPS mutant T164W in complex with 476A, IPP & Ca · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.